Skip to main content
Top
Published in: Skeletal Radiology 7/2019

01-07-2019 | Lymphoma | Scientific Article

B-cell peripheral neurolymphomatosis: MRI and 18F-FDG PET/CT imaging characteristics

Authors: Anthony H. DeVries, Benjamin M. Howe, Robert J. Spinner, Stephen M. Broski

Published in: Skeletal Radiology | Issue 7/2019

Login to get access

Abstract

Objective

To examine the MRI and 18F-FDG PET/CT imaging characteristics of peripheral neurolymphomatosis.

Materials and methods

All institutional cases of neurolymphomatosis with an MRI or 18F-FDG PET/CT from 2000 to 2017 were retrospectively reviewed. Included cases were biopsy-proven neurolymphomatosis or lymphoma patients with clinical and imaging evidence of neurolymphomatosis that resolved after chemotherapy. Multiple imaging parameters and clinical characteristics were recorded.

Results

There were 27 cases of B-cell neurolymphomatosis in 25 patients (18 M, 7 F; mean age 64.6 ± 10.0 years). Of the total cases, 85% (23/27) were biopsy-proven. Most were diagnosed after disease progression or recurrence (20/27, 74%), and presented with isolated nerve involvement (18/27, 67%). Bone marrow biopsy (17/19, 89%) and CSF cytology (16/23, 70%) were usually negative. On 18F-FDG PET/CT, neurolymphomatosis presented as a linear or fusiform (23/26, 88%), FDG-avid (average SUVmax: 7.1 ± 4.5, range, 1.5–17.0) mass, and on MRI as a T2-weighted hyperintense (21/22, 95%), enhancing (21/22, 95%), linear or fusiform mass (19/22, 86%), with associated muscle denervation (14/22, 64%). FDG avidity was significantly higher in patients with muscular denervation on MRI (mean SUVmax 8.2 ± 4.6 vs. 4.3 ± 2.3, p = 0.04).

Conclusions

B-cell neurolymphomatosis most commonly manifests as T2-weighted hyperintense, enhancing linear or fusiform neural enlargement associated with muscular denervation on MRI, with intense FDG activity on PET/CT. It is most often an isolated site of disease, presenting after progression or recurrence. A familiarity with the imaging appearance of neurolymphomatosis can help refine the differential diagnosis, direct biopsy, and aid in accurate diagnosis.
Literature
2.
go back to reference Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-Oncology. 2010;12(2):212–5.CrossRefPubMed Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-Oncology. 2010;12(2):212–5.CrossRefPubMed
3.
go back to reference Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun. 2012;33(9):907–16.CrossRefPubMed Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun. 2012;33(9):907–16.CrossRefPubMed
4.
go back to reference Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neuro-Oncol. 2008;90(1):77–83.CrossRef Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neuro-Oncol. 2008;90(1):77–83.CrossRef
5.
go back to reference Kosa SC, Peller PJ, Klein CJ. T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology. 2009;72(1):98.CrossRefPubMed Kosa SC, Peller PJ, Klein CJ. T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology. 2009;72(1):98.CrossRefPubMed
6.
go back to reference Mahan MA, Ladak A, Johnston PB, Seningen JL, Amrami KK, Spinner RJ. Unique occurrence of mucosa-associated lymphoid tissue lymphoma disseminated to peripheral nerves. J Surg Orthop Adv. 2013;22(4):321–5.CrossRefPubMed Mahan MA, Ladak A, Johnston PB, Seningen JL, Amrami KK, Spinner RJ. Unique occurrence of mucosa-associated lymphoid tissue lymphoma disseminated to peripheral nerves. J Surg Orthop Adv. 2013;22(4):321–5.CrossRefPubMed
7.
go back to reference Canh NX, Tan NV, Tung TT, Son NT, Maurea S. (18)F-FDG PET/CT in neurolymphomatosis: report of 3 cases. Asia Ocean J Nucl Med Biol. 2014;2(1):57–64.PubMedPubMedCentral Canh NX, Tan NV, Tung TT, Son NT, Maurea S. (18)F-FDG PET/CT in neurolymphomatosis: report of 3 cases. Asia Ocean J Nucl Med Biol. 2014;2(1):57–64.PubMedPubMedCentral
8.
go back to reference Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J. 2012;18(5):463–8.CrossRefPubMed Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J. 2012;18(5):463–8.CrossRefPubMed
9.
go back to reference Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115(24):5005–11.CrossRefPubMedPubMedCentral Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115(24):5005–11.CrossRefPubMedPubMedCentral
10.
go back to reference Kanter P, Zeidman A, Streifler J, Marmelstein V, Even-Sapir E, Metser U, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol. 2005;74(1):66–9.CrossRefPubMed Kanter P, Zeidman A, Streifler J, Marmelstein V, Even-Sapir E, Metser U, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol. 2005;74(1):66–9.CrossRefPubMed
11.
go back to reference Lin M, Kilanowska J, Taper J, Chu J. Neurolymphomatosis—diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol. 2008;26(1):43–5.CrossRefPubMed Lin M, Kilanowska J, Taper J, Chu J. Neurolymphomatosis—diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol. 2008;26(1):43–5.CrossRefPubMed
12.
go back to reference van den Bent MJ, de Bruin HG, Bos GM, Brutel de la Riviere G, Sillevis Smitt PA. Negative sural nerve biopsy in neurolymphomatosis. J Neurol. 1999;246(12):1159–63.CrossRefPubMed van den Bent MJ, de Bruin HG, Bos GM, Brutel de la Riviere G, Sillevis Smitt PA. Negative sural nerve biopsy in neurolymphomatosis. J Neurol. 1999;246(12):1159–63.CrossRefPubMed
13.
go back to reference Hutchings M, Specht L. PET/CT in the management of haematological malignancies. Eur J Haematol. 2008;80(5):369–80.CrossRefPubMed Hutchings M, Specht L. PET/CT in the management of haematological malignancies. Eur J Haematol. 2008;80(5):369–80.CrossRefPubMed
14.
go back to reference Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol. 2000;24(9):1257–65.CrossRefPubMed Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol. 2000;24(9):1257–65.CrossRefPubMed
15.
go back to reference Davidson T, Kedmi M, Avigdor A, Komisar O, Chikman B, Lidar M, et al. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma. 2018;59(2):348–56.CrossRefPubMed Davidson T, Kedmi M, Avigdor A, Komisar O, Chikman B, Lidar M, et al. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma. 2018;59(2):348–56.CrossRefPubMed
16.
17.
go back to reference Laumonerie P, Capek S, Amrami KK, Dyck PJ, Spinner RJ. Targeted fascicular biopsy of the brachial plexus: rationale and operative technique. Neurosurg Focus. 2017;42(3):E9.CrossRefPubMed Laumonerie P, Capek S, Amrami KK, Dyck PJ, Spinner RJ. Targeted fascicular biopsy of the brachial plexus: rationale and operative technique. Neurosurg Focus. 2017;42(3):E9.CrossRefPubMed
18.
go back to reference Capek S, Amrami KK, Dyck PJ, Spinner RJ. Targeted fascicular biopsy of the sciatic nerve and its major branches: rationale and operative technique. Neurosurg Focus. 2015;39(3):E12.CrossRefPubMed Capek S, Amrami KK, Dyck PJ, Spinner RJ. Targeted fascicular biopsy of the sciatic nerve and its major branches: rationale and operative technique. Neurosurg Focus. 2015;39(3):E12.CrossRefPubMed
19.
go back to reference Hong CM, Lee SW, Lee HJ, Song BI, Kim HW, Kang S, et al. Neurolymphomatosis on F-18 FDG PET/CT and MRI findings: a case report. Nucl Med Mol Imaging. 2011;45(1):76–8.CrossRefPubMed Hong CM, Lee SW, Lee HJ, Song BI, Kim HW, Kang S, et al. Neurolymphomatosis on F-18 FDG PET/CT and MRI findings: a case report. Nucl Med Mol Imaging. 2011;45(1):76–8.CrossRefPubMed
20.
go back to reference Trevisan AC, Ribeiro FB, Itikawa EN, Alexandre LS, Pitella FA, Santos AC, et al. 18F-FDG PET/CT/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis. Indian J Nucl Med. 2017;32(1):77–8. Trevisan AC, Ribeiro FB, Itikawa EN, Alexandre LS, Pitella FA, Santos AC, et al. 18F-FDG PET/CT/MRI fusion images showing cranial and peripheral nerve involvement in neurolymphomatosis. Indian J Nucl Med. 2017;32(1):77–8.
21.
go back to reference Dyck PJB, Suanprasert N, Mauermann M, Amrami K, Spinner R, Dyck P. Peripheral nerve lymphoma: clinical, electrophysiological, radiographic and pathological findings. Neurology. 2015;84(24):P2.002. Dyck PJB, Suanprasert N, Mauermann M, Amrami K, Spinner R, Dyck P. Peripheral nerve lymphoma: clinical, electrophysiological, radiographic and pathological findings. Neurology. 2015;84(24):P2.002.
22.
go back to reference Thawait SK, Chaudhry V, Thawait GK, Wang KC, Belzberg A, Carrino JA, et al. High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol. 2011;32(8):1365–72.CrossRefPubMed Thawait SK, Chaudhry V, Thawait GK, Wang KC, Belzberg A, Carrino JA, et al. High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol. 2011;32(8):1365–72.CrossRefPubMed
23.
go back to reference Descamps MJ, Barrett L, Groves M, Yung L, Birch R, Murray NM, et al. Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry. 2006;77(9):1087–9.CrossRefPubMedPubMedCentral Descamps MJ, Barrett L, Groves M, Yung L, Birch R, Murray NM, et al. Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry. 2006;77(9):1087–9.CrossRefPubMedPubMedCentral
24.
go back to reference Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, et al. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014;34(7):1987–2007.CrossRefPubMed Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, et al. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014;34(7):1987–2007.CrossRefPubMed
25.
go back to reference Ahlawat S, Chhabra A, Blakely J. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 2014;24(1):171–92.CrossRefPubMed Ahlawat S, Chhabra A, Blakely J. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 2014;24(1):171–92.CrossRefPubMed
26.
go back to reference Lim AT, Clucas D, Khoo C, Parameswaran BK, Lau E. Neurolymphomatosis: MRI and (18) FDG-PET features. J Med Imaging Radiat Oncol. 2016;60(1):92–5.CrossRefPubMed Lim AT, Clucas D, Khoo C, Parameswaran BK, Lau E. Neurolymphomatosis: MRI and (18) FDG-PET features. J Med Imaging Radiat Oncol. 2016;60(1):92–5.CrossRefPubMed
27.
go back to reference Capek S, Hebert-Blouin MN, Puffer RC, Martinoli C, Frick MA, Amrami KK, et al. Tumefactive appearance of peripheral nerve involvement in hematologic malignancies: a new imaging association. Skelet Radiol. 2015;44(7):1001–9.CrossRef Capek S, Hebert-Blouin MN, Puffer RC, Martinoli C, Frick MA, Amrami KK, et al. Tumefactive appearance of peripheral nerve involvement in hematologic malignancies: a new imaging association. Skelet Radiol. 2015;44(7):1001–9.CrossRef
Metadata
Title
B-cell peripheral neurolymphomatosis: MRI and 18F-FDG PET/CT imaging characteristics
Authors
Anthony H. DeVries
Benjamin M. Howe
Robert J. Spinner
Stephen M. Broski
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 7/2019
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-019-3145-3

Other articles of this Issue 7/2019

Skeletal Radiology 7/2019 Go to the issue